Sienna Biopharmaceuticals
2010
FOUNDED
PUBLIC
STATUS
31-40
EMPLOYEES
SNNAQ
STOCK SYMBOL
1
INVESTMENTS
$0.02
SHARE PRICE
(As of Tuesday Closing)
Description
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.
Website
Formerly Known As
Sienna Labs
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
PINX
Primary Office
- 30699 Russell Ranch Road
- Suite 140
- Westlake Village, CA 91362
- United States
+1 (818) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Sienna Biopharmaceuticals’s full profile, request a free trial.
Sienna Biopharmaceuticals Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.01 - $3.47 | $727K | $0.03 | -$1.93 | 2.61M | 30.9M |
Sienna Biopharmaceuticals Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | (13,007) | 15,053 | 287,833 | |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (52,417) | (73,314) | (50,715) | (21,095) |
| Net Income | (47,951) | (73,471) | (50,545) | (21,162) |
| Total Assets | 43,492 | 107,306 | 136,847 | 62,377 |
| Total Debt | 0 | 30,125 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Sienna Biopharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Sienna Biopharmaceuticals‘s full profile, request access.
Request full access to PitchBookSienna Biopharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is reserved for PitchBook Platform users. To explore Sienna Biopharmaceuticals‘s full profile, request access.
Request full access to PitchBookSienna Biopharmaceuticals Competitors (7)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dermata | Venture Capital-Backed | San Diego, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 000000 00000000000 | Venture Capital-Backed | Carlsbad, CA | 0 | 000.00 | 00000000000 | 000.00 |
| 0000000 0000000000 | Private Equity-Backed | Pune, India | 000 | 0000 | 0000000 0000 | 0000 |
| 0000000 | Formerly VC-backed | Menlo Park, CA | 000 | 00000 | 000000&0 | 00000 |
| 000000 000000 | Corporate Backed or Acquired | San Diego, CA | 000 | 000.00 | 000000000 | 000.00 |
Sienna Biopharmaceuticals Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 | 06-Dec-2016 | 000000000000000000 | 00000 | Biotechnology |
Sienna Biopharmaceuticals Executive Team (18)
7 Former Executives
You’re viewing 5 of 18 executives. Get the full list »Sienna Biopharmaceuticals Board Members (15)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Dennis Fenton Ph.D | Self | Board Member | 000 0000 | |
| Donna Janson | Self | Board Member | 000 0000 | |
| Erle Mast | Self | Board Member | 000 0000 | |
| Frederick Beddingfield III | Sienna Biopharmaceuticals | Chief Executive Officer & Board Member | 000 0000 | |
| James Hindman | Self | Board Member | 000 0000 |
6 Former Board Members
You’re viewing 5 of 15 board members. Get the full list »